PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21068207-0	2011	Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model.	Flavonols	121-130	UDP glucuronosyltransferase family 1 member A9	Homo sapiens	74-80	
21068207-3	2011	This article aims to construct position (3-OH)-specific comparative molecular field analysis (CoMFA) models to describe UDP-glucuronosyltransferase (UGT) 1A9-mediated glucuronidation of flavonols, which can be used to design poor UGT1A9 substrates.	Flavonols	186-195	UDP glucuronosyltransferase family 1 member A9	Homo sapiens	120-157	
21068207-4	2011	The kinetics of recombinant UGT1A9-mediated 3-O-glucuronidation of 30 flavonols was characterized, and kinetic parameters (K(m), V(max), CL(int)) were obtained.	Flavonols	70-79	UDP glucuronosyltransferase family 1 member A9	Homo sapiens	28-34	
21068207-6	2011	To model UGT1A9-mediated glucuronidation, 30 flavonols were split into the training (23 compounds) and test (7 compounds) sets.	Flavonols	45-54	UDP glucuronosyltransferase family 1 member A9	Homo sapiens	9-15	
21068207-10	2011	In conclusion, the approach of coupling CoMFA analysis with a pharmacophore-based structural alignment is viable for constructing a predictive model for regiospecific glucuronidation rates of flavonols by UGT1A9.	Flavonols	192-201	UDP glucuronosyltransferase family 1 member A9	Homo sapiens	205-211